August 10, 2022

Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database

JCO Oncology Practice
Ray E et al
June 3, 2022

Retrospective analysis of real-world management of EGFR-mutated advanced NSCLC, after first-line EGFR-TKI treatment: US treatment patterns, attrition, and survival data

Drugs - Real World Outcomes
Nieva J et al
November 17, 2020

Utilizing Data Visualization to Identify Survival and Treatment Differences Between Women With De Novo and Recurrent Metastatic Breast Cancer

Clinical Breast Cancer
Gilbert A et al
March 11, 2021

Identification of transgender people with cancer in electronic health records (EHR): Recommendations based on CancerLinQ observations

JCO Oncology Practice
Alpert AB et al
January 7, 2022

Quantitating and assessing interoperability between electronic health records

Journal of the American Medical Informatics Association
Bernstam E et al
January 5, 2022

The Chasm between Cancer Quality Measures and EHR Data Quality

JCO Clinical Cancer Informatics
Schorer A et al
February 1, 2021

Impact of Broadening Trial Eligibility Criteria for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: Real-World Analysis of Select ASCO-Friends Recommendations

Cancer Clinical Research
Harvey D et al
June 1, 2021

Summary of the 12 Most Common Cancers in the CancerLinQ Discovery (CLQD) Database

JCO Clinical Cancer Informatics
Potter D et al
October 2, 2020

Development of CancerLinQ, a health information learning platform from multiple Electronic Health Record (EHR) systems to support improved quality of care

JCO Clinical Cancer Informatics
Potter D et al


May 7, 2023

Patient characteristics, treatment patterns, and factors of biomarker testing among patients with advanced non-small cell lung cancer (ANSCLC) in the US, 2012-2020

ISPOR 2023
Yang M et al
May 1, 2023

Association of clinical trial enrollment and mortality amongst patients with advanced prostate cancer

AUA Annual Meeting 2023

Pessoa RR et al

April 30, 2023

Variation of hormonal agent usage with postoperative radiation therapy: Results from a population based cohort of prostate cancer patients in community oncology practices

AUA Annual Meeting 2023
Pessoa RR et al
February 17, 2023

Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer (la/mUC) in the US

ASCO Genitourinary Cancers Symposium 2023
Kearney M et al
December 12, 2022

Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis

ASH Annual Meeting & Exposition 2022
Cooper JD et al
December 11, 2022

Secondary primary malignancies (SPMs) in adolescent and young adults (AYAs) with multiple myeloma (MM): An ASCO CancerLinQ analysis

ASH Annual Meeting & Exposition 2022
Gibson SJ et al
December 10, 2022

Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021

ASH Annual Meeting & Exposition 2022
Bhandari S et al
December 6, 2022

Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

San Antonio Breast Conference Symposium 2022
Sukumar JS et al
September 10, 2022

Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutations

European Society for Medical Oncology 2022
Altorki NK et al